Related Experiment Video
Updated: Nov 26, 2025
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Morel-Lavallee Syndrome: A Rare Tumefactive Lesion
Mohamed Labied1, Siham Salam1, Salma Jabri1
1Pediatric Radiology Department, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy of Casablanca, Morocco.
Abstract:
First described by the French surgeon Maurice Morel-Lavallee in 1853, Morel-Lavallee syndrome (MLS) is a serolymphatic effusion resulting from tangential injury to richly vascularized tissues. The imaging characteristics may be variable over time due to lesion progression and the eventual organization of a fibrous capsule. We report a case of extensive MLS in the lower leg of a 12-year-old child. We discuss the ultrasound and magnetic resonance imaging findings and describe the differential diagnoses.
Learning Points:
The diagnosis of Morel-Lavallee syndrome is based on clinical examination and imaging techniques.The post-traumatic context is important for diagnosis.Morphological aspects depend on lesion progression and the eventual organization of a fibrous capsule.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
Related Concept Videos
02:23Abnormal Proliferation
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...